On June 27th, Gelunhui | The Centers for Disease Control and Prevention (CDC) of the United States narrowed the recommended range of respiratory syncytial virus vaccines for the elderly this year, and temporarily did not recommend the use of these vaccines by adults under 60 years of age. The CDC's decision is consistent with the decision of its external advisory group, which voted to recommend that all adults aged 75 and above, as well as those aged 60 to 74 who are at increased risk of severe RSV due to their physical condition, be vaccinated. Jefferies Financial analyst Peter Welford said that the new recommendations could reduce the solvable market size of RSV vaccines in the United States in 2024-25 from 93 million (including adults under 60) to about 55 million. He added that as "less complicated recommendations may help popularize", the use of injections will expand in the long term.
美国疾病预防控制中心缩小RSV疫苗注射年龄建议
The CDC in the USA has revised their recommendations for the age at which RSV vaccines should be administered.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.